Dr. Cho Chi Shing

Scientific Officer (Medical)
Clinical Oncology
Queen Elizabeth Hospital
E-mail: williamcscho@gmail.com

Fields of interest:

MicroRNA, proteomics, nasopharyngeal carcinoma, non-small cell lung carcinoma, Chinese medicine

Recent publications:

Wu K, Huang RS, House L, Cho WC.
Next-generation sequencing for lung cancer.
Future Oncol (2013)

Wang Y, Li Y, Liu X, Cho WC.
Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents.
Curr Cancer Drug Targets (2013)

Qian B, Nag SA, Su Y, Voruganti S, Qin JJ, Zhang R, Cho WC.
miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.
Curr Cancer Drug Targets (2013)

Li SG, Chen HY, Ou-Yang CS, Wang XX, Yang ZJ, Tong Y, Cho WC.
The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.
PLoS One 8(2):e57604 (2013)

Cho WC, Roukos DH.
Trastuzumab emtansine for advanced HER2-positive breast cancer and beyond: genome landscape-based targets.
Expert Rev Anticancer Ther 13(1):5-8 (2013)

Cho WC, Ziogas DE, Katsios C, Roukos DH.
Emerging personalized oncology: sequencing and systems strategies.
Future Oncol 8(6):637-641 (2012)

Cho WC.
MicroRNAs as therapeutic targets and their potential applications in cancer therapy.
Expert Opin Ther Targets 2012;16(8):747-759 (2012)

Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, Zhang MY, Sun Y, Huang BJ, Chen M, He QM, Jiang N, Chen L, Cho WC, Yun JP, Zeng J, Liu LZ, Li L, Guo Y, Wang HY, Ma J.
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Lancet Oncol 13(6):633-641 (2012)

Chan LW, Wang FF, Cho WC.
Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer.
Curr Top Med Chem 12(8):920-926 (2012)

Cho WC.
Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance.
Expert Rev Mol Diagn 11(7):691-694 (2011)